4.7 Article

Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for COVID-19 in Brazil

Related references

Note: Only part of the references are listed.
Review Peripheral Vascular Disease

Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19

Chisa Matsumoto et al.

Summary: COVID-19 can result in long-term symptoms, known as long COVID, which may have an impact on hypertension and cardiovascular diseases. This article summarizes the potential effects of long COVID on hypertension and related organs, and discusses the influence of age and sex on long COVID. Lastly, it explores areas of uncertainty and future directions for improved understanding and prognosis of clinical problems associated with COVID-19.

HYPERTENSION RESEARCH (2023)

Review Medicine, Research & Experimental

Post-COVID-19 Condition

Ani Nalbandian et al.

Summary: An estimated 10-15% of COVID-19 patients may develop post-COVID-19 condition, with common lingering symptoms such as shortness of breath, fatigue, high heart rate, and memory and cognitive dysfunction. The prevalence and duration of these symptoms remain uncertain due to heterogeneous research methods and limited patient follow-up. Risk factors may include female sex and underlying respiratory or psychiatric disease, and supportive therapies are the mainstay of treatment. Most patients experience symptom reduction within 1 year, but further research using standardized methods is needed to understand the pervasiveness and long-term consequences of this condition.

ANNUAL REVIEW OF MEDICINE (2023)

Article Medicine, General & Internal

Two-Years Follow-Up of Symptoms and Return to Work in Complex Post-COVID-19 Patients

Erika Van Wambeke et al.

Summary: COVID-19 patients with long-lasting symptoms benefited from a coordination team, but the efficacy of the therapeutic strategy still needs to be determined. Phone consultations and personalized support showed some improvement in symptoms and ability to return to work after 15 and 22 months of COVID infection. Common symptoms such as fatigue and neurocognitive disorders did not resolve, but dyspnea, anxiety, and chest pain were significantly reduced.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Cell Biology

Abnormal white matter changes in Alzheimer?s disease based on diffusion tensor imaging: A systematic review

Yu Chen et al.

Summary: Alzheimer's disease (AD) is a degenerative neurological disease in elderly individuals. Diffusion tensor imaging (DTI) is widely used to understand the central nervous system mechanism and find biomarkers for early stages of AD. Based on multilevel analysis methods of DTI, AD patients show extensive microstructural damage, structural disconnection, and topological abnormalities in specific regions. The classification accuracy of SCD and normal controls is 92.68%, while MCI, d-AD, and normal controls have a classification accuracy of over 97%. Future research directions and limitations of current DTI-based AD research are discussed.

AGEING RESEARCH REVIEWS (2023)

Review Clinical Neurology

Systematic Review and Meta-Analysis of Clinically Relevant Executive Functions Tests Performance after COVID-19

Boris B. Velichkovsky et al.

Summary: COVID-19 has prolonged effects on general health, wellbeing, and cognitive functioning, including impaired executive functions. However, there is a lack of studies using differentiated performance measures to assess the exact functions that get impaired.

BEHAVIOURAL NEUROLOGY (2023)

Article Clinical Neurology

Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study

Marco Paolini et al.

Summary: Cognitive impairment is a common residual symptom in COVID-19 survivors and is associated with various brain changes. This study investigated the neural correlates of subjective cognitive decline using multimodal imaging in a sample of 58 COVID-19 survivors. The findings revealed widespread white matter disruption and abnormal functional connectivity in the brains of individuals with cognitive complaints. These results suggest a potential brain signature of cognitive decline in COVID-19 survivors and may aid in the identification of therapeutic targets for mitigating long-term cognitive dysfunction.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)

Review Cell Biology

Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics

Sujata Thakur et al.

Summary: Alzheimer's disease is a neurodegenerative disease characterized by amyloid beta accumulation. Inflammatory cytokines play diverse roles in neurodegeneration and neuroprotection. There is a cross-link between gut microbiota and neuroinflammation in Alzheimer's disease.

INFLAMMATION (2023)

Article Infectious Diseases

Risk factors, health outcomes, healthcare services utilization, and direct medical costs of patients with long COVID

Lilac Tene et al.

Summary: This study examined the prevalence and medical costs of treating long COVID using data from a large health provider in Israel. The findings showed that long COVID is associated with increased healthcare resource utilization and direct medical costs.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Review Medicine, General & Internal

Risk Factors Associated With Post-COVID-19 Condition A Systematic Review and Meta-analysis

Vasiliki Tsampasian et al.

Summary: Post-COVID-19 condition (PCC) is a complex disorder that has affected millions of people globally. Identifying potential risk factors to understand who is at risk of developing PCC is important for early clinical support.

JAMA INTERNAL MEDICINE (2023)

Review Endocrinology & Metabolism

The bidirectional association between diabetes and long-COVID-19-A systematic review

Jessica L. Harding et al.

Summary: Evidence suggests that diabetes may increase the risk of post-acute sequelae of COVID-19 (PASC), and new-onset diabetes is a potential complication of COVID-19. A systematic review of longitudinal studies found that diabetes was a significant risk factor for PASC in some studies, while others did not find a significant association. Similarly, COVID-19 was significantly associated with new-onset diabetes in most studies.

DIABETES RESEARCH AND CLINICAL PRACTICE (2023)

Article Medicine, General & Internal

Structural brain changes in patients with post-COVID fatigue: a prospective observational study

Josephine Heine et al.

Summary: This study explores the clinical characteristics, associated structural imaging changes, and influences on fatigue severity in patients with post-COVID syndrome. The findings reveal that the fatigue experienced by these patients is associated with structural changes in the thalamus and basal ganglia, providing insights into understanding post-COVID fatigue and related neuropsychiatric complications.

ECLINICALMEDICINE (2023)

Article Clinical Neurology

Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life

Sara Poletti et al.

Summary: The study investigated cognitive functioning in COVID-19 survivors 6 months after hospital discharge and found that depressive symptoms negatively impacted cognitive functions and quality of life. COVID-19 survivors showed cognitive impairment, with depression affecting cognitive functions and overall quality of life.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)

Article Behavioral Sciences

Neuropsychological deficits in patients with cognitive complaints after COVID-19

Carmen Garcia-Sanchez et al.

Summary: Subjective cognitive complaints are reported in COVID-19 patients across different disease severities. This study found that attention abilities were widely affected in post-COVID patients with subjective complaints, and were associated with deficits in executive functions, learning, and long-term memory. These cognitive deficits were largely unrelated to clinical factors such as hospitalization and disease duration.

BRAIN AND BEHAVIOR (2022)

Review Clinical Neurology

Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis

Lucia Crivelli et al.

Summary: This study conducted a systematic review and meta-analysis on the cognitive effects of COVID-19 in adults without prior cognitive impairment. The results showed that post-COVID-19 patients experienced impairments in executive functions, attention, and memory. A meta-analysis comparing recovered COVID-19 patients and healthy controls demonstrated lower general cognition in the post-infection period up to 7 months.

ALZHEIMERS & DEMENTIA (2022)

Article Psychiatry

Association of depression and COVID-induced PTSD with cognitive symptoms after COVID-19 illness

Nadia A. Liyanage-Don et al.

Summary: Many patients recovering from COVID-19 experience persistent psychological and cognitive symptoms even months after clearing the virus. This study found a strong association between depression, COVID-induced PTSD, and cognitive symptoms following acute COVID-19 illness.

GENERAL HOSPITAL PSYCHIATRY (2022)

Review Immunology

Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review

Chen Chen et al.

Summary: This study reveals a substantial prevalence of post-COVID-19 condition worldwide. Hospitalized patients have a higher prevalence compared to non-hospitalized ones. Fatigue is the most commonly reported symptom.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 is associated with changes in brain structure in UK Biobank

Gwenaelle Douaud et al.

Summary: Through long-term observation of participants' MRI images, it was found that COVID-19 infection is associated with abnormal brain changes, including a reduction in gray matter thickness in the orbitofrontal cortex and parahippocampal gyrus, greater changes in markers of tissue damage in regions functionally connected to the primary olfactory cortex, and a greater reduction in global brain size. Infected individuals also showed significant cognitive decline.

NATURE (2022)

Article Multidisciplinary Sciences

Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort

Viet-Thi Tran et al.

Summary: About 10% of people infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) experience post COVID-19 disease. This study analyzed data from a French disease cohort and found that among patients symptomatic after 2 months, 85% still reported symptoms one year after their symptom onset. Symptoms showed different trends over time, with some decreasing, some remaining stable, and some increasing in prevalence. The study provides important insights into the natural history of post COVID-19 disease.

NATURE COMMUNICATIONS (2022)

Review Immunology

Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review

Areez Shafqat et al.

Summary: This article reviews the immune dysregulation caused by COVID-19 and highlights relevant discussions in the scientific community. The management approaches for COVID-19 and the immune cell signatures characterizing disease severity remain contentious.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation

Anthony Fernandez-Castaneda et al.

Summary: COVID survivors may experience lingering neurological symptoms similar to cognitive impairment related to cancer therapy. Research has found that respiratory SARS-CoV-2 infection can cause white-matter-selective microglial reactivity and affect neurogenesis and CCL11 levels.
Review Geriatrics & Gerontology

Post-COVID-19 human memory impairment: A PRISMA-based systematic review of evidence from brain imaging studies

Dan Shan et al.

Summary: This study compares and summarizes the literature on the relationship between COVID-19-induced neuropathological changes observed through neuroimaging scans and memory symptoms experienced by recovered patients. The findings suggest a correlation between structural and functional abnormalities in various brain regions, particularly in the frontal, parietal, and temporal regions, and memory impairments in COVID-19 survivors.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Cytokine Storm Signature in Patients with Moderate and Severe COVID-19

Olga Kalinina et al.

Summary: This study investigated the levels of cytokines in patients with moderate and severe COVID-19 and found elevated levels of pro-inflammatory factors, chemokines, anti-inflammatory factors, and growth factors. Patients with severe disease had higher levels of FGF-2/FGF-basic, IL-1 beta, and IL-7 compared to healthy donors. Pneumonia lung injury was positively correlated with levels of EGF, IP-10, and MCP-3, and negatively correlated with IL-12 p40. Pro-inflammatory factors were negatively correlated with the frequency of circulating Th17-like cells and follicular Th cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Geriatrics & Gerontology

Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?

Yuanjie Sun et al.

Summary: Neuroinflammation, which contributes to neurological and psychiatric diseases, can be caused by various factors including viral infection, autoimmune disease, inflammation from peripheral organs, mental stress, metabolic disorders, and lifestyle. The mechanisms of neuroinflammation caused by inflammation of peripheral organs involve disruption of the blood-brain barrier, activation of glial cells associated with systemic immune activation, and effects on autonomic nerves via the organ-brain axis.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Review Psychiatry

Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19

Jennifer A. Frontera et al.

Summary: Neuropsychiatric symptoms are a prominent feature of post-acute sequelae of COVID-19 (PASC), including cognitive impairment, sleep difficulties, depression, posttraumatic stress, and substance use disorders. The mechanisms of neuropsychiatric PASC are not well understood, and there is a lack of a standard definition for the syndrome. Studies have found that at least one PASC neuropsychiatric symptom has been reported in as many as 90% of hospitalized patients after 6 months of COVID-19 and in approximately 25% of nonhospitalized adults with COVID-19.

JAMA PSYCHIATRY (2022)

Article Critical Care Medicine

A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

Daniel Munblit et al.

Summary: This international consensus study aims to identify the core outcomes of post-COVID-19 condition, providing a standardized assessment framework for clinical care and global research.

LANCET RESPIRATORY MEDICINE (2022)

Review Clinical Neurology

A Systematic Review on Neurological Aspects of COVID-19: Exploring the Relationship Between COVID-19-Related Olfactory Dysfunction and Neuroinvasion

Sujata Purja et al.

Summary: The neurological spectrum of COVID-19 is diverse, with direct neuroinvasion of SARS-CoV-2 being rare. The association between olfactory dysfunction and positive CSF PCR results for SARS-CoV-2 is controversial, and further studies are needed for more insight into this topic.

FRONTIERS IN NEUROLOGY (2022)

Article Psychiatry

Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?

Sean Lynch et al.

Summary: This study assessed the utility of the Montreal Cognitive Assessment (MoCA) in screening for cognitive impairment in post-acute sequelae of COVID-19 (PASC). The results showed that the MoCA may not be accurate for detecting mild or more severe degrees of diminished neurocognitive test performance in PASC. Therefore, patients with persistent cognitive complaints in the setting of PASC, even if they score in the normal range on the MoCA, should be referred for formal neurocognitive assessment.

GENERAL HOSPITAL PSYCHIATRY (2022)

Review Neurosciences

Myelin and oligodendrocyte lineage cell dysfunctions: New players in the etiology and treatment of depression and stress-related disorders

Enrica Boda

Summary: Depressive disorders are complex and recent studies have shown the important role of glial cells, particularly oligodendroglia, in their pathogenesis and treatment. Targeting oligodendroglia may offer novel therapeutic options for depression.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

Review Hematology

The looming storm: Blood and cytokines in COVID-19

Supreet Kaur et al.

Summary: COVID-19, caused by the novel coronavirus, has led to a global pandemic with high mortality rates attributed mainly to multiple organ dysfunction such as respiratory failure, sepsis, cardiac failure, kidney injury, or coagulopathy. Hematological abnormalities, elevated cytokines, and thrombotic complications are crucial prognostic factors for worse outcomes in COVID-19 patients. Understanding the pathophysiology of these hematological abnormalities is essential for effective management and treatment strategies.

BLOOD REVIEWS (2021)

Review Biochemistry & Molecular Biology

The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression

Naoise Mac Giollabhui et al.

Summary: The study found bidirectional prospective associations between depression and inflammatory biomarkers, especially for IL-6. However, the strength and importance of this relationship may be obscured by the heterogeneity in depression and methodological differences in studies.

MOLECULAR PSYCHIATRY (2021)

Article Neurosciences

Diffusional Kurtosis Imaging in the Diffusion Imaging in Python Project

Rafael Neto Henriques et al.

Summary: Diffusional Kurtosis Imaging (DKI) quantifies non-Gaussian diffusion in biological tissue, providing better sensitivity to microstructural alterations in health and diseases compared to traditional diffusion imaging methods.

FRONTIERS IN HUMAN NEUROSCIENCE (2021)

Article Engineering, Environmental

Ambient NO2 exposure sex-specifically impairs myelin and contributes to anxiety and depression-like behaviors of C57BL/6J mice

Dan Li et al.

Summary: NO2 is a common indoor and outdoor air pollutant with potential health risks including anxiety and depression. Exposure to NO2 was found to induce anxiety and depression-like behaviors in male mice but not female mice in a study. Genomic analysis suggested that the effects of NO2 on nerve behavior disorders in male mice may be related to signal transduction pathways and myelin sheath ultrastructure. Prolactin may play a key role in the sex-specific neurobehavioral disorder in male mice caused by NO2 exposure.

JOURNAL OF HAZARDOUS MATERIALS (2021)

Article Medicine, General & Internal

1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study

Lixue Huang et al.

LANCET (2021)

Article Biochemistry & Molecular Biology

Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts

Yuri Milaneschi et al.

Summary: The study found inflammation to be uniformly associated with core depressive symptoms of low mood and anhedonia, as well as somatic/neurovegetative symptoms of fatigue, altered sleep, and appetite changes. Inconsistent associations were observed for anxiety. The IL-6/IL-6R pathway may play a causative role in depression.

MOLECULAR PSYCHIATRY (2021)

Review Immunology

Monocytes and Macrophages in COVID-19

Rainer Knoll et al.

Summary: COVID-19 is a contagious viral disease caused by SARS-CoV-2, characterized primarily by respiratory symptoms of varying severity. Macrophages play crucial roles in host defense, and understanding their phenotypes is essential for unraveling the disease's pathological mechanisms.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Medicine, General & Internal

Is a Cytokine Storm Relevant to COVID-19?

Pratik Sinha et al.

JAMA INTERNAL MEDICINE (2020)

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

Article Critical Care Medicine

Acute kidney injury in patients with SARS-CoV-2 infection

Adrien Joseph et al.

ANNALS OF INTENSIVE CARE (2020)

Article Medicine, General & Internal

Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study

Yiping Lu et al.

ECLINICALMEDICINE (2020)

Article Neurosciences

The Lifespan Human Connectome Project in Aging: An overview

Susan Y. Bookheimer et al.

NEUROIMAGE (2019)

Article Biochemical Research Methods

BIDS apps: Improving ease of use, accessibility, and reproducibility of neuroimaging data analysis methods

Krzysztof J. Gorgolewski et al.

PLOS COMPUTATIONAL BIOLOGY (2017)

Article Psychiatry

Brazilian norms and effects of age and education on the Hayling and Trail Making Tests

Nicolle Zimmermann et al.

TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Diffusion MRI Noise Mapping Using Random Matrix Theory

Jelle Veraart et al.

MAGNETIC RESONANCE IN MEDICINE (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Gibbs-Ringing Artifact Removal Based on Local Subvoxel-Shifts

Elias Kellner et al.

MAGNETIC RESONANCE IN MEDICINE (2016)

Article Neurosciences

Denoising of diffusion MRI using random matrix theory

Jelle Veraart et al.

NEUROIMAGE (2016)

Article Multidisciplinary Sciences

The brain imaging data structure, a format for organizing and describing outputs of neuroimaging experiments

Krzysztof J. Gorgolewski et al.

SCIENTIFIC DATA (2016)

Review Geriatrics & Gerontology

Brain metabolic stress and neuroinflammation at the basis of cognitive impairment in Alzheimer's disease

Fernanda G. De Felice et al.

FRONTIERS IN AGING NEUROSCIENCE (2015)

Article Psychology, Clinical

Validation of the Brazilian Portuguese Version of Geriatric Anxiety Inventory - GAI-BR

Patricia Nitschke Massena et al.

INTERNATIONAL PSYCHOGERIATRICS (2015)

Article Neurosciences

Permutation inference for the general linear model

Anderson M. Winkler et al.

NEUROIMAGE (2014)

Review Psychology, Clinical

Cognitive impairment in depression: a systematic review and meta-analysis

P. L. Rock et al.

PSYCHOLOGICAL MEDICINE (2014)

Review Geriatrics & Gerontology

Proinflammatory Cytokines, Aging, and Age-Related Diseases

Martin Michaud et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2013)

Article Neurosciences

The minimal preprocessing pipelines for the Human Connectome Project

Matthew F. Glasser et al.

NEUROIMAGE (2013)

Article Psychiatry

Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample

Marcio Henrique Gomes-Oliveira et al.

REVISTA BRASILEIRA DE PSIQUIATRIA (2012)

Article Psychology, Experimental

Effect Size Estimates: Current Use, Calculations, and Interpretation

Catherine O. Fritz et al.

JOURNAL OF EXPERIMENTAL PSYCHOLOGY-GENERAL (2012)

Article Computer Science, Interdisciplinary Applications

N4ITK: Improved N3 Bias Correction

Nicholas J. Tustison et al.

IEEE TRANSACTIONS ON MEDICAL IMAGING (2010)

Article Multidisciplinary Sciences

Multiplexed Echo Planar Imaging for Sub-Second Whole Brain FMRI and Fast Diffusion Imaging

David A. Feinberg et al.

PLOS ONE (2010)

Article Public, Environmental & Occupational Health

Validation of geriatric depression scale in a general outpatient clinic

EMP Paradela et al.

REVISTA DE SAUDE PUBLICA (2005)

Article Neurosciences

Suggestions for utilization of the mini-mental state examination in Brazil

SMD Brucki et al.

ARQUIVOS DE NEURO-PSIQUIATRIA (2003)